Outcomes of CD20 Bispecific Antibodies after CD19 CAR T-cell Therapy in mantle cell lymphoma: A Multicenter Analysis from the Collaborative U.S. Bispecific Consortium (CUBIC)
Ajay Major(University of Colorado Cancer Center), Andrew Jallouk(Vanderbilt University Medical Center), Robert Redd(Harvard University), Yazeed Sawalha(Cleveland Clinic), Pierre Stéphan(Boston University), Gulrayz Ahmed(Medical College of Wisconsin), Steven M. Bair(University of Colorado Cancer Center), Shakthi Bhaskar(Vanderbilt University Medical Center), Allison M. Bock(Mayo Clinic), Esther Drill(Memorial Sloan Kettering Cancer Center), Amy Ayers(The University of Texas MD Anderson Cancer Center), Reid W. Merryman(Harvard University), Chijioke Nze(The University of Texas MD Anderson Cancer Center), Preetesh Jain(The University of Texas MD Anderson Cancer Center), Jennifer L. Crombie(Dana-Farber Cancer Institute), Jomel Meeko Manzano(City Of Hope National Medical Center), Swetha Thiruvengadam, Lei Feng, Mehdi Hamadani, Narendranath Epperla, Matthew A. Lunning, Ayushi Chauhan, Manali Kamdar, Lorenzo Falchi, Sairah Ahmed, Geoffrey Shouse(City Of Hope National Medical Center)
Cited by 0
Related Papers
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
|Cell Reports|2018|366
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
|Blood|2017|332